Loss of Siglec-14 reduces the risk of COPD exacerbation (33), and inhaled corticosteroids could exert two opposite effects depending on the patients’ phenotypes of Siglec-5 and Siglec-14 (34). The gene discussed is SIGLEC14; the disease is chronic obstructive pulmonary disease.